Literature DB >> 15750687

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).

Hajime Nawata1, Satoshi Soen, Ryoichi Takayanagi, Ikuko Tanaka, Kunio Takaoka, Masao Fukunaga, Toshio Matsumoto, Yasuo Suzuki, Hiroyuki Tanaka, Saeko Fujiwara, Takami Miki, Akira Sagawa, Yoshiki Nishizawa, Yoshiki Seino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15750687     DOI： 10.1007/s00774-004-0596-x

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN： 0914-8779            Impact factor:   2.626


× No keyword cloud information.
  69 in total

1.  Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EDITOR-J) study.

Authors:  Yoshiya Tanaka; Hiroko Mori; Takatoshi Aoki; Tatsuya Atsumi; Yutaka Kawahito; Hisanori Nakayama; Shigeto Tohma; Yuji Yamanishi; Hitoshi Hasegawa; Kazuhide Tanimura; Nobuo Negoro; Yukitaka Ueki; Atsushi Kawakami; Katsumi Eguchi; Kazuyoshi Saito; Yosuke Okada
Journal:  J Bone Miner Metab       Date:  2015-08-26       Impact factor: 2.626

2.  High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.

Authors:  H Sato; N Kondo; T Nakatsue; Y Wada; J Fujisawa; J J Kazama; T Kuroda; Y Suzuki; M Nakano; N Endo; I Narita
Journal:  Osteoporos Int       Date:  2017-04-13       Impact factor: 4.507

3.  An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis.

Authors:  L Caplan; A E Hines; E Williams; A V Prochazka; K G Saag; F Cunningham; E Hutt
Journal:  Osteoporos Int       Date:  2010-04-01       Impact factor: 4.507

4.  Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid.

Authors:  H Kaji; M Yamauchi; T Yamaguchi; T Sugimoto
Journal:  Osteoporos Int       Date:  2009-11-14       Impact factor: 4.507

5.  Glucocorticoid-induced osteoporosis: treatment update and review.

Authors:  Lisa-Ann Fraser; Jonathan D Adachi
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

Review 6.  Management of glucocorticoid-induced osteoporosis.

Authors:  Juliet Compston
Journal:  Nat Rev Rheumatol       Date:  2010-02       Impact factor: 20.543

7.  The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.

Authors:  H Sato; N Kondo; Y Wada; T Nakatsue; S Iguchi; J Fujisawa; J J Kazama; T Kuroda; M Nakano; N Endo; I Narita
Journal:  Osteoporos Int       Date:  2015-10-30       Impact factor: 4.507

8.  Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.

Authors:  K Ebina; T Noguchi; M Hirao; J Hashimoto; S Kaneshiro; M Yukioka; H Yoshikawa
Journal:  Osteoporos Int       Date:  2016-01       Impact factor: 4.507

9.  Oral alendronate can suppress bone turnover but not fracture in kidney transplantation recipients with hyperparathyroidism and chronic kidney disease.

Authors:  Sakura Yamamoto; Atsushi Suzuki; Hitomi Sasaki; Sahoko Sekiguchi-Ueda; Shogo Asano; Megumi Shibata; Nobuki Hayakawa; Shuji Hashimoto; Kiyotaka Hoshinaga; Mitsuyasu Itoh
Journal:  J Bone Miner Metab       Date:  2012-10-18       Impact factor: 2.626

10.  Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status.

Authors:  B L Langdahl; F Marin; E Shane; H Dobnig; J R Zanchetta; M Maricic; K Krohn; K See; M R Warner
Journal:  Osteoporos Int       Date:  2009-04-07       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.